Vor Biopharma (VOR) Shares Outstanding (2020 - 2026)

Vor Biopharma (VOR) has 5 years of Shares Outstanding (Entity) data on file, last reported at $9.9 million in Q4 2025.

• On a quarterly basis, Shares Outstanding (Entity) rose 187.37% year-over-year to $9.9 million in Q4 2025; TTM through Dec 2025 was $9.9 million, a 187.37% increase from a year earlier, with the FY2025 full-year figure at $9.9 million, up 187.37% from the prior year.
• Shares Outstanding (Entity) for Q4 2025 stood at $9.9 million, up from $6.7 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for VOR reached as high as $9.9 million in Q4 2025 and fell as low as $1.1 million in Q1 2021.
• Historically, Shares Outstanding (Entity) has averaged $3.5 million across 5 years, with a median of $3.4 million in 2023.
• Across the five-year window, Shares Outstanding (Entity) advanced 1.18% in 2024 and jumped 187.37% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $1.9 million in 2021, then grew by 5.82% to $2.0 million in 2022, then surged by 71.68% to $3.4 million in 2023, then gained by 1.18% to $3.4 million in 2024, then soared by 187.37% to $9.9 million in 2025.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $9.9 million in Q4 2025, $6.7 million in Q3 2025, and $6.3 million in Q2 2025.